Ovarian Cancer Molecular Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Ovarian Cancer Molecular Diagnostics Market size was estimated at USD 1.2 billion in 2019 and is expected to grow at a CAGR of 6% during the forecast period 2021-2027. 

Ovarian cancer is the 7th most common cause of death and morbidity in women worldwide. It is a complex neoplasm that often affects women over the age of 65. Various studies have identified an age group of 50-79 years as the mean of diagnosis. A woman has a 1 in 75 chance of getting ovarian cancer in her lifetime and a 1 in 100 chance of dying. The prevalence of the disease tends to vary with age and race, the latter being higher in underdeveloped countries. From 1982 to 2008, the incidence of ovarian cancer in Europe rose sharply from 4.9 per 100,000 women to 6.1 per 100,000 women. Ovarian cancer accounted for 81.8% of all cancer cases in the United States in 2012.

Market Segments

On the basis of product type

• PCR
• FISH
• DNA Sequencing
• Gene Chip

On the basis of the end users/applications

• Clinical Diagnosis
• Drug Screening
• Research

Key Players

• Roche
• Foundationmedicine
• Tellgen
• Sansure
• Premed
• Berryoncology
• Helixgen
• Annoroad

Scope of the Report

The research study analyzes the global Ovarian Cancer Molecular Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Ovarian Cancer Molecular Diagnostics Market Report

1. What was the Ovarian Cancer Molecular Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Ovarian Cancer Molecular Diagnostics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Ovarian Cancer Molecular Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.